Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:48:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study. Updated the revision label to v3.3.1, replacing the previous PubMed publication description (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T14:58:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removal of the government funding operating status banner from the page does not affect the trial details or study content. Core study information and links remain intact. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:21:52.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI/layout adjustments and a refreshed last update timestamp, with core study data such as eligibility criteria, contacts, and locations remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:41.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:20:22.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - Added new contact numbers (646-888-4206, 646-888-4197, 646-888-4188). - Removed reference to the old revision (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-28T03:20:20.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.